Bridget Martell MA, MD

Bridget Martell MA, MD has a diverse work experience spanning various roles and companies. Bridget currently serves as the President and Chief Executive Officer of Artizan Biosciences, where they are involved in creating precision therapies for chronic inflammation and immune dysregulation. Bridget is also an Independent Board Director at POINT Biopharma, Aligos Therapeutics, and Achieve Life Sciences, where they provide strategic guidance in developing new classes of compounds and targeted therapies for various diseases.

Bridget Martell is the Founder and Managing Director of BAM Consultants, LLC, a company that offers expertise in pharmaceutical and diagnostic clinical development, regulatory affairs, and medical affairs. Bridget provides strategic and operational guidance in areas such as portfolio strategy, product life cycle management, and clinical trial program management. Additionally, they are an Entrepreneur in Residence at Yale University Ventures and a Healthcare Venture Partner at AlleyCorp, where they play a key role in founding and funding companies in the healthcare sector.

Prior to their current roles, Bridget Martell held positions at Kura Oncology, Inc. as a Senior Scientific Advisor, Acting Chief Medical Officer, and Vice President of Clinical Development. Bridget was responsible for providing scientific and strategic input in oncology drug development. Bridget also served as an Associate Clinical Professor at Yale-New Haven Hospital, where they contributed to medical education and clinical practice in the General Internal Medicine division.

Earlier in their career, Bridget Martell worked at RRD International, LLC as the Chief Medical Officer and later as a Strategic Advisor. In these roles, they provided scientific and strategic advice for clinical drug development across various therapeutic areas.

Overall, Bridget Martell's work experience showcases their expertise in pharmaceutical development, clinical trial design, and strategic decision-making in the healthcare industry.

Bridget Martell MA, MD completed their Bachelor of Science (BS) in Microbiology at Cornell University from 1985 to 1988. Bridget then pursued a Master of Arts (MA) in Biochemistry/Molecular Immunology at Boston University School of Medicine from 1990 to 1993. Continuing their education, Bridget earned their Medical Doctor (MD) degree from the Chicago Medical School at Rosalind Franklin University of Medicine and Science between 1993 and 1997.

After obtaining their MD, Bridget Martell enrolled in Yale University School of Medicine for further training. Bridget served as a Resident in Internal Medicine from 1997 to 2000 and subsequently became the Chief Resident in Internal Medicine from 2000 to 2001. Bridget then participated in the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine from 2003 to 2005, focusing on the field of Medicine.

Throughout their educational journey, Bridget Martell has demonstrated a strong commitment to acquiring knowledge and skills in various medical disciplines.